EI
AXSM icon

Ellevest Inc’s Axsome Therapeutics AXSM Stock Holding History

Ellevest Inc’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-58
Closed -$2K – 1399
2022
Q1 		$2K Sell
58
-7
-11% -$217 ﹤0.01% 1173
2021
Q4 		$2K Hold
65
– – ﹤0.01% 1138
2021
Q3 		$2K Buy
65
+48
+282% +$1.87K ﹤0.01% 1105
2021
Q2 		$1K Buy
+17
New +$1.02K ﹤0.01% 1120
2020
Q4 		– Sell
-1
Closed – – 1191
2020
Q3 		$0 Sell
1
-10
-91% -$779 ﹤0.01% 1137
2020
Q2 		$1K Buy
+11
New +$847 ﹤0.01% 955

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return